Characteristics of patients at the time of the FibroScan examination
| All patients (n = 711) | Patients with liver biopsy (n = 354) | F3F4 fibrosis patients (n = 144) | |
|---|---|---|---|
| Results are given as mean (SD) or *n (%). | |||
| BMI, body mass index; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γ-glutamyl-transpeptidase; US ultrasonographic. | |||
| Males (%)* | 403 (57) | 206 (58) | 102 (71) |
| Age (y) | 52 (13) | 50 (13) | 53 (12) |
| BMI (kg/m2) | 24.2 (4.2) | 24.5 (4.3) | 25.2 (4.3) |
| AST (UI/l) | 59.5 (86.1) | 71.3 (110.5) | 94.7 (138.7) |
| ALT (UI/l) | 79.2 (108.3) | 82.7 (106.6) | 108.1 (119.1) |
| GGT (UI/l) | 136 (245) | 159 (229) | 206 (272) |
| Total bilirubin (μmol/l) | 16.9 (31.5) | 19.7 (37.3) | 27.3 (44) |
| Platelet count (G/l) | 209 (87) | 213 (91) | 165 (83) |
| Prothrombin time (%) | 90 (14) | 89 (15) | 82 (17) |
| Factor V (%) | 88.6 (18.5) | 92.5 (15) | 80.5 (20.5) |
| Albumin (g/l) | 38.5 (5.6) | 38.5 (5.2) | 36.1 (6.3) |
| α Fetoprotein (ng/ml) | 49 (456) | 31 (105) | 54 (270) |
| Fibrosis score (%)* | |||
| No or mild fibrosis | 111 (31) | ||
| Moderate fibrosis | 99 (28) | ||
| Severe fibrosis | 49 (14) | ||
| Cirrhosis | 95 (27) | ||
| Past history of ascites* | 18 (13) | ||
| Past history of bleeding varices* | 14 (10) | ||
| Hepatocellular carcinoma* | 19 (13) | ||
| Oesophageal varices stage 2/3* | 42 (29) | ||
| US splenomegaly* | 48 (33) | ||